Patents by Inventor Gangadharan Subramanian

Gangadharan Subramanian has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070037162
    Abstract: The present invention is based on the discovery of novel polymorphisms (SNPs) in the genes known in the art to contribute to osteoporosis. Such polymorphisms can lead to a variety of disorders that are mediated/modulated by a variant osteoporosis associated protein. The present invention provides reagents used for detecting and expressing the variant nucleic acid/protein sequence as well as methods of identifying and using these variants.
    Type: Application
    Filed: July 19, 2004
    Publication date: February 15, 2007
    Applicant: APPLERA CORPORATION
    Inventors: J. Venter, Jinghui Zhang, Xiangjun Liu, William Rowe, Anibal Cravchik, Francis Kalush, Ashwinikumar Naik, Gangadharan Subramanian, Trevor Woodage
  • Publication number: 20070037168
    Abstract: The present invention is based on the discovery of novel polymorphisms (SNPs) in the genes known in the art to contribute to inflammatory and autoimmune disorders. Such polymorphisms can lead to a variety of disorders that are mediated/modulated by a variant inflammatory and autoimmune disorders associated protein. The present invention provides reagents used for detecting and expressing the variant nucleic acid/protein sequence as well as methods of identifying and using these variants.
    Type: Application
    Filed: January 12, 2005
    Publication date: February 15, 2007
    Applicant: APPLERA CORPORATION
    Inventors: J. Venter, Jinghui Zhang, Xiangjun Liu, William Rowe, Anibal Cravchik, Francis Kalush, Ashwinikumar Naik, Gangadharan Subramanian, Trevor Woodage
  • Publication number: 20070037165
    Abstract: The present invention is based on the discovery of novel polymorphisms (SNPs) in the genes known in the art to contribute to human disease. Such polymorphisms can lead to a variety of disorders that are mediated/modulated by a variant human disease associated protein. The present invention provides reagents used for detecting and expressing the variant nucleic acid/protein sequence as well as methods of identifying and using these variants.
    Type: Application
    Filed: September 15, 2004
    Publication date: February 15, 2007
    Applicant: APPLERA CORPORATION
    Inventors: J. Venter, Jinghui Zhang, Xiangjun Liu, William Rowe, Anibal Cravchik, Francis Kalush, Ashwinikumar Naik, Gangadharan Subramanian, Trevor Woodage
  • Publication number: 20060111915
    Abstract: A hypothesis generation system includes a related concepts datastore recording relationships between core concepts in a field of study. A recognition module performs automatic recognition of a hypothesis recognition pattern respective of contents of the related concepts datastore. The recognition module records a hypothetical relationship between core concepts of the datastore based on recognition of the pattern.
    Type: Application
    Filed: July 12, 2005
    Publication date: May 25, 2006
    Applicant: Applera Corporation
    Inventors: Peter Li, Mark Yandell, William Majoros, Michael Harris, Rui Ru Ji, Kendra Biddick, Gangadharan Subramanian, Jian Wang
  • Publication number: 20050240583
    Abstract: A literature pipeline corresponds to a document navigation system having a datastore of direct links between pre-defined core concepts found in a document corpus. A link identification module identifies indirect links between core concepts selected by a user based on connection of direct links through at least one core concept not selected by the user. An output communicates identified links to the user.
    Type: Application
    Filed: November 23, 2004
    Publication date: October 27, 2005
    Inventors: Peter Li, Mark Yandell, William Majoros, Michael Harris, Rui Ji, Kendra Biddick, Gangadharan Subramanian, Jian Wang
  • Publication number: 20050147987
    Abstract: The present invention is based on the discovery of novel polymorphisms (SNPs) in the genes known in the art to contribute to type II diabetes and obesity. Such polymorphisms can lead to a variety of disorders that are mediated/modulated by a variant type II diabetes and obesity associated protein. The present invention provides reagents used for detecting and expressing the variant nucleic acid/protein sequence as well as methods of identifying and using these variants.
    Type: Application
    Filed: July 19, 2004
    Publication date: July 7, 2005
    Applicant: APPLERA CORPORATION (NY)
    Inventors: J. Venter, Jinghui Zhang, Xiangjun Liu, William Rowe, Anibal Cravchik, Francis Kalush, Ashwinikumar Naik, Gangadharan Subramanian, Trevor Woodage
  • Patent number: 6900016
    Abstract: The present invention is based on the discovery of novel polymorphisms (SNPs) in the genes known in the art to contribute to inflammatory and autoimmune disorders. Such polymorphisms can lead to a variety of disorders that are mediated/modulated by a variant inflammatory and autoimmune disorders associated protein. The present invention provides reagents used for detecting and expressing the variant nucleic acid/protein sequence as well as methods of identifying and using these variants.
    Type: Grant
    Filed: September 10, 2001
    Date of Patent: May 31, 2005
    Assignee: Applera Corporation
    Inventors: J. Craig Venter, Jinghui N. Zhang, Xiangjun Liu, William Rowe, Anibal Cravchik, Francis Kalush, Ashwinikumar Naik, Gangadharan Subramanian, Trevor Woodage
  • Patent number: 6825336
    Abstract: The present invention is based on the discovery of novel polymorphisms (SNPs) in the genes known in the art to contribute to osteoporosis. Such polymorphisms can lead to a variety of disorders that are mediated/modulated by a variant osteoporosis associated protein. The present invention provides reagents used for detecting and expressing the variant nucleic acid/protein sequence as well as methods of identifying and using these variants.
    Type: Grant
    Filed: September 10, 2001
    Date of Patent: November 30, 2004
    Assignee: Applera Corporation
    Inventors: J. Craig Venter, Jinghui N. Zhang, Xiangjun Liu, William Rowe, Anibal Cravchik, Francis Kalush, Ashwinikumar Naik, Gangadharan Subramanian, Trevor Woodage
  • Patent number: 6812339
    Abstract: The present invention is based on the discovery of novel polymorphisms (SNPs) in the genes known in the art to contribute to human disease. Such polymorphisms can lead to a variety of disorders that are mediated/modulated by a variant human disease associated protein. The present invention provides reagents used for detecting and expressing the variant nucleic acid/protein sequence as well as methods of identifying and using these variants.
    Type: Grant
    Filed: September 10, 2001
    Date of Patent: November 2, 2004
    Assignee: Applera Corporation
    Inventors: J. Craig Venter, Jinghui N. Zhang, Xiangjun Liu, William Rowe, Anibal Cravchik, Francis Kalush, Ashwinikumar Naik, Gangadharan Subramanian, Trevor Woodage
  • Publication number: 20040009509
    Abstract: The present invention provides amino acid sequences of proteins that are encoded by genes within the human genome that show high homology to known human disease proteins, the PDG encoded proteins of the present invention. The present invention specifically provides isolated protein and nucleic acid molecules, and uses of these compositions, such as methods and kits to identify modulators of the PDG encoded proteins.
    Type: Application
    Filed: April 23, 2003
    Publication date: January 15, 2004
    Applicant: APPLERA CORPORATION
    Inventor: Gangadharan Subramanian
  • Patent number: 6051385
    Abstract: The invention provides compositions a methods of identifying and testing therapeutics against HSV infection, and in particular, compositions comprising receptors which enable cell specific entry of HSV. The invention also provides a novel DNA sequence that encodes a protein B5T74 that confers the ability of herpes simplex virus (HSV) to infect and replicate in otherwise non-permissive cells. Also provided are vectors comprising the isolated nucleic acids encoding HSV receptors in host suitable for expression of the nucleic acids encoding the HSV receptors, fragments of the HSV receptors, or homologs of the HSV receptor. Further provided is a porcine cell system which expresses a herpes simplex virus receptor, but does not express endogenous, HSV entry receptors.
    Type: Grant
    Filed: October 22, 1997
    Date of Patent: April 18, 2000
    Assignee: The Regents of the University of Michigan
    Inventors: A. Oveta Fuller, Qing-xue Li, Ning-hun C. McLaren, Aleida Perez, Gangadharan Subramanian